Prediabetes: Diagnostics, Protocol, Consultation

Diagnostics are built on a panel of 50+ biomarkers: HbA1c, fasting glucose and insulin, the HOMA-IR insulin resistance index, a lipid panel, hs-CRP, liver and kidney function markers, plus vitamin D and iron status — together these show where a patient sits on the metabolic decline curve, not just the current sugar reading.

The standard workup most patients get elsewhere — fasting glucose or a single HbA1c — does not capture insulin resistance, which typically develops earlier and isn't reliably reflected in either marker alone. That narrower approach can miss prediabetes at a stage when changes are still reversible, and it leaves no baseline data to track whether an intervention is working.